Sensex reclaims 30K in opening trade, Nifty around 9350; pharma stocks gain
Market Opening Update:
Benchmark indices opened on a positive note, with indices achieving key milestones in the opening trade.
Benchmark indices opened on a positive note, with indices achieving key milestones in the opening trade.
The Sensex clocked 30,000 before coming lower. The Bank Nifty and midcap index were up around half a percent.
The Sensex was up 62.04 points at 29995.29, while the Nifty up 25.65 points at 9342.50.
The Sensex was up 62.04 points at 29995.29, while the Nifty up 25.65 points at 9342.50.
The market breadth was very healthy as 399 shares advanced against a decline of 97 shares, while 35 shares were unchanged.
ONGC, Cipla, Aurobindo Pharma and Grasim were top gainers on both the indices, while Bharti Airtel, Hero MotoCorp, and Bharti Infratel lost the most.
GMDC was up around 11 percent after its results, while Blue Star was also higher around 1 percent due to better earnings performance.
The S&P 500 fell on Tuesday after edging up to an intra-day record high for the second straight session, while Apple became the first US company to close with a market capitalization above USD 800 billion.
For more real-time market information and new :-
Call Us @ - 9329336363
Email Us @ - info@researchinfotech.in
Visit - http://www.researchinfotech.in/
FACEBOOK TWITTER LINKEDIN GOOGLE+
ONGC, Cipla, Aurobindo Pharma and Grasim were top gainers on both the indices, while Bharti Airtel, Hero MotoCorp, and Bharti Infratel lost the most.
GMDC was up around 11 percent after its results, while Blue Star was also higher around 1 percent due to better earnings performance.
The S&P 500 fell on Tuesday after edging up to an intra-day record high for the second straight session, while Apple became the first US company to close with a market capitalization above USD 800 billion.
For more real-time market information and new :-
Call Us @ - 9329336363
Email Us @ - info@researchinfotech.in
Visit - http://www.researchinfotech.in/
FACEBOOK TWITTER LINKEDIN GOOGLE+
No comments: